Dr. Daniel Patrick Morin, MD, MPH

Dr. Morin practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Morin's NPI, 1306011044, was assigned on April 24, 2008. Dr. Morin graduated from UMass Chan Medical School in 2000. Dr. Morin holds California license A84589.

Dr. Morin's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Morin's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Morin is also affiliated with California Pacific Medical Center Davies Campus. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Morin to 3 more hospitals, 4 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morin practices, 6 sites in all. Vendor and product names are available with a free account.

Clinical cardiac electrophysiology is Dr. Morin's primary specialty in the NPI Registry, under taxonomy code 207RC0001X. Dr. Morin is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Morin's licenses on file in 3 states: California, Louisiana and New York.

Dmand AI lists atrial fibrillation and flutter, cardiac arrhythmia, heart blockage, intermittent racing heartbeat (PSVT), pacemaker or defibrillator implantation, pacemaker replacement, sick sinus syndrome and ventricular tachycardia among the conditions Dr. Morin treats.

CMS data shows 1,028 Medicare services from Dr. Morin across 16 procedure codes in 2024, for 446 Medicare patients. Medicare paid $47,735 for them.

CMS counts 446 Medicare patients who saw Dr. Morin in 2024. The largest group is 65 to 74, with 169 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Morin's median patient age at 66, with 49% women.

In 2024, Dr. Morin wrote 2,926 Medicare Part D claims for 560 patients. 58% of them were for generic drugs. CMS names the drug for 2,761 of them, across 25 drugs with 11 or more claims each, at $1,157,608 in total drug cost. In 2023, CMS named 3,045 claims across 29 drugs.

Dr. Morin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Morin as offering telehealth. CMS counts 19 procedures of pacemaker insertion or repair by Dr. Morin, more than 70% of the clinicians it reports for that procedure.

Dmand AI links 95 papers to Dr. Morin, published from 2007 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Atrial Fibrillation, Death, Sudden, Cardiac and Electrocardiography. Dr. Morin has published most often in Prog Cardiovasc Dis. Dr. Morin's most frequent co-authors are Robert M. Bober, MD, Carl J. Lavie, MD and Paul A. Rogers, MD, PhD.

Dmand AI links Dr. Morin to 3 clinical trials. Conditions studied include Ventricular Fibrillation, Hypertension, Pulmonary and Death, Sudden, Cardiac.

CMS Open Payments shows 648 general payments to Dr. Morin from 30 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 63% of the total. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) paid the most, $168,253. It also lists 2 research payments totaling $2,562 from 2023 to 2024.

Dmand AI lists 1 award for Dr. Morin, most recently CMS Stage 1 EHR in 2013.

Dr. Morin graduated from UMass Chan Medical School in 2000. Dr. Morin is a member of ACC and Heart Rhythm Society.

Dr. Morin is in network with 7 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.